Suchergebnisse - "Messina, Monica"

PubPharm (107)

1

Implementing a Staff-Led Smoking Cessation Intervention in a Diverse Safety-Net Rheumatology Clinic : a pre-post scalability study in a low resource setting

enthalten in: Arthritis care & research | 2024

von Brandt, J. | Ramly, E. | Lim, S. | +4

2

Unlocking the potential of synthetic patients for accelerating clinical trials : Results of the first GIMEMA experience on acute myeloid leukemia patients

enthalten in: EJHaem | 2024

von Piciocchi, A. | Cipriani, M. | Messina, M. | +13

3

A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia : an EWALL collaborative study

enthalten in: Blood advances | 2024

von Enshaei, A. | Joy, M. | Butler, E. | +11

4

Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Foà, R. | Bassan, R. | Elia, L. | +13

5

Rheumatology High Blood Pressure Protocol Reduces Disparities, But Delays Remain for External Primary Care

enthalten in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | 2024

von Ferguson, S. | Hanlon, B. | Ramly, E. | +4

6

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia : results of the GIMEMA LAL1913 trial

enthalten in: Blood advances | 2023

von Bassan, R. | Chiaretti, S. | Della Starza, I. | +29

7

Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice : A GIMEMA Survey

enthalten in: Journal of clinical medicine | 2023

von Breccia, M. | Piciocchi, A. | Abruzzese, E. | +12

8

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile : results of the GIMEMA phase II LLC1518 - VERITAS study

enthalten in: Haematologica | 2023

von Mauro, F. | Starza, I. | Messina, M. | +44

CommentIn: Haematologica. 2023 Aug 01;108(8):1975-1978. - PMID 36815386

9

ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß2 adrenoceptor agonist (MABA) radiolabelled at both functional moieties

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2023

von Ghiglieri, A. | Messina, M. | Cenacchi, V. | +4

10

ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings

enthalten in: Leukemia & lymphoma | 2023

von Chiaretti, S. | Taherinasab, A. | Della Starza, I. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]